The Discounted Cash Flow (DCF) valuation of Abbott Laboratories (ABT) is 150.99 USD. With the latest stock price at 124.95 USD, the upside of Abbott Laboratories based on DCF is 20.8%.
Based on the latest price of 124.95 USD and our DCF valuation, Abbott Laboratories (ABT) is a buy. buying Abbott stocks now will result in a potential gain of 20.8%.
| Range | Selected | |
| WACC / Discount Rate | 6.6% - 8.6% | 7.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 98.41 - 336.17 | 150.99 |
| Upside | -21.2% - 169.0% | 20.8% |